Royal Bank of Canada boosted its stake in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 50.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 570,035 shares of the company’s stock after buying an additional 190,604 shares during the period. Royal Bank of Canada owned 0.54% of BlackRock Capital Allocation Term Trust worth $8,055,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Geneos Wealth Management Inc. grew its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after acquiring an additional 1,582 shares during the period. N.E.W. Advisory Services LLC boosted its position in shares of BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after purchasing an additional 1,200 shares in the last quarter. Parallel Advisors LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $47,000. Brown Brothers Harriman & Co. grew its stake in BlackRock Capital Allocation Term Trust by 450.0% in the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock worth $81,000 after purchasing an additional 4,500 shares during the period. Finally, Global Retirement Partners LLC grew its stake in BlackRock Capital Allocation Term Trust by 1,856.5% in the fourth quarter. Global Retirement Partners LLC now owns 8,687 shares of the company’s stock worth $123,000 after purchasing an additional 8,243 shares during the period. 36.12% of the stock is owned by institutional investors.
BlackRock Capital Allocation Term Trust Trading Up 0.2%
BCAT opened at $16.08 on Tuesday. The stock has a fifty day simple moving average of $15.76 and a two-hundred day simple moving average of $15.24. BlackRock Capital Allocation Term Trust has a 12-month low of $13.73 and a 12-month high of $16.18.
BlackRock Capital Allocation Term Trust Announces Dividend
About BlackRock Capital Allocation Term Trust
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Recommended Stories
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
